Can Prescription Refill Feedback to Physicians Improve Patient Adherence?

American Journal of the Medical Sciences

Volumn 327, Issue 1, 2004, Pages 19-24

  Schectman, Joel M ^a   Schorling, John B ^a   Nadkarni, Mohan M ^a   Voss, John D ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Adherence; Drug therapy; Feedback; Physician education

Indexed keywords

ANTIHYPERTENSIVE AGENT; ISOPHANE INSULIN; METFORMIN; ROSIGLITAZONE;

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETES MELLITUS; FEEDBACK SYSTEM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PATIENT EDUCATION; PHYSICIAN; PRESCRIPTION; PRIMARY MEDICAL CARE; PUBLIC HEALTH SERVICE; RESIDENT; UNIVERSITY HOSPITAL;

EID: 0347004554     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-200401000-00005     Document Type: Article

References (40)

1. Haynes RB, McKibbon KA, Kanani R. Systematic review of randomized trials of interventions to assist patients to follow prescriptions for medications. Lancet 1996;348:383-6.
2. Diehl AK, Bauer RL, Sugarek NJ. Correlates of medication compliance in non-insulin-dependent diabetes mellitus. South Med J 1987;80:332-5.
3. Chousa FP, Guillen VFG, Otero MD, et al. Usefulness of six indirect methods to evaluate drug therapy compliance in non insulin dependent diabetes mellitus. Rev Clin Esp 1997;197:555-9.
4. Peterson GM, McLean S, Senator GB. Determinants of patient compliance, control, presence of complications, and handicap in non-insulin-dependent diabetes. Aust N Z J Med 1984;14:135-41.
5. Schectman JM, Nadkarni MM, Voss JD. Diabetes metabolic control and medication adherence in an indigent population. Diabetes Care 2002;25:1015-21.
6. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
7. Anonymous. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UK-PDS) Group [published erratum appears in Lancet 1998;352:1557]. Lancet 1998;352:854-65.
8. Anonymous. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UK-PDS) Group [published erratum appears in Lancet 1998;352:1557]. Lancet 1998;352:854-65.
9. Anonymous. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group [published erratum appears in Lancet 1999;354:602]. Lancet 1998;352:837-53.
10. Anonymous. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group [published erratum appears in Lancet 1999;354:602]. Lancet 1998;352:837-53.
11. Patton K, Meyers J, Lewis BE. Enhancement of adherence among patients with hypertension. Am J Manag Care 1997;3:1693-8.
12. Varma S, McElnay JC, Hughes CM, et al. Pharmaceutical care of patients with congestive heart failure: interventions and outcomes. Pharmacotherapy 1999;19:860-9.
13. Morrison A, Wertheimer AI, Berger ML. Interventions to improve antihypertensive drug adherence: a quantitative review of trials. Formulary 2000;35:234-46.
14. Roter DL, Hall JA, Merisca R, et al. Effectiveness of interventions to improve patient adherence. Med Care 1998;36:1138-61.
15. McInnes GT. Integrated approaches to management of hypertension: promoting treatment acceptance. Am Heart J 1999;138:252-5.
16. Inui TS, Yourtee EL, Williamson JW. Improved outcomes in hypertension after physician tutorials: a controlled clinical trial. Ann Intern Med 1976;84:646-51.
17. Bond WS, Hussar DA. Detection methods and strategies for improving medication adherence. Am J Hosp Pharm 1991;48:1978-88.
18. Rudd P. Clinicians and patients with hypertension: unsettled issues about adherence. Am Heart J 1995;130:572-9.
19. Cramer JA. Microelectronic systems for monitoring and enhancing patient adherence with medication regimens. Drugs 1995;49:321-7.
20. Aronson JK, Hardman M. ABC of monitoring drug therapy. Patient compliance. BMJ 1992;305:1009-11.
21. Arnet I, Haefeli WE. Overconsumption detected by electronic drug monitoring requires subtle interpretation. Clin Pharmacol Ther 2000;67:44-7.
22. Farmer KC. Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther 1999;21:1074-90.
23. Choo PW. Rand CS, Inui TS, et al. Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy. Med Care 1999;37:846-57.
24. Grymonpre RE, Didur CD, Montgomery PR, et al. Pill count, self-report, and pharmacy claims data to measure medication adherence in the elderly. Ann Pharmacother 1998;32:749-54.
25. Christensen DB, Williams B, Goldberg HI, et al. Assessing adherence to antihypertensive medication using computer-based pharmacy records. Med Care 1997;25:1164-70.
26. Smith NL, Psaty BM, Heckbert SR, et al. The reliability of medication inventory methods compared to serum levels of cardiovascular drugs in the elderly. J Clin Epidemiol 1999;52:143-6.
27. Caron HS. Adherence: the case for objective measurement. J Hypertens Suppl 1985;3:S11-7.
28. Steiner JF, Prochazka AV. The assessment of refill adherence using pharmacy records: methods, validity, and applications. J Clin Epidemiol 1997;50:105-16.
29. Bieszk N, Patel R, Heaberlin A, et al. Detection of medication nonadherence through review of pharmacy claims data. Am J Health Syst Pharm 2003;60:360-6.
30. Schectman JM, Bovjberg VE, Voss JD. Predictors of adherence in an indigent rural population. Med Care 2002;40:1294-300.
31. Stuart B, Zacker C. Who bears the burden of Medicaid drug copayment policies? Health Aff (Millwood) 1999;18:201-12.
32. Johnson RE, Goodman MJ, Hornbrook MC, et al. The effect of increased prescription drug cost-sharing on medical care utilization and expenses of elderly HMO members. Med Care 1997;35:1119-31.
33. Headrick LA, Speroff T, Pelecanos HI, et al. Efforts to improve adherence with the national Cholesterol Education Program guidelines. Results of a randomized controlled trial. Arch Intern Med 1992;152:2490-6.
34. Schectman JM, Elinsky EG, Pawlson LG. The effect of education and feedback on thyroid function testing strategies of primary care clinicians. Arch Intern Med 1991;151:2163-6.
35. Schectman JM, Kanwal NK, Schroth WS, et al. The effect of an education and feedback intervention on group and network model HMO physician prescribing behavior. Med Care 1995;33:139-44.
36. Balas EA, Weingarten S, Garb CT, et al. Improving preventive care by prompting physicians. Arch Intern Med 2000;160:301-8.
37. McPhee SJ, Bird JA, Jenkins CN, et al. Promoting cancer screening. A randomized, controlled trial of three interventions. Arch Intern Med 1989;149:1866-72.
38. Tierney WM, Hui SL, McDonald CJ. Delayed feedback of physician performance versus immediate reminders to perform preventive care: effects on physician compliance. Med Care 1986;24:659-66.
39. Stone TT, Kivlahan CH, Cox KR. Evaluation of physician preferences for guideline implementation. Am J Med Qual 1999;14:170-7.
40. Elliott WJ. Adherence strategies. Curr Opin Nephrol Hypertens 1994;3:271-8.